Cardiometabolic healthcare for men with prostate cancer: an MD Anderson Cancer Center experience

BACKGROUND: Men diagnosed with prostate cancer are at risk for competing morbidity and mortality due to cardiometabolic disease given their advanced age at diagnosis, high prevalence of pre-existing risk factors, and receipt of systemic therapy that targets the androgen receptor (AR). Expert panels...

Descripción completa

Detalles Bibliográficos
Autores principales: Hahn, Andrew W., Thoman, Whittney, Koutroumpakis, Efstratios, Abdulla, Amer, Subudhi, Sumit K., Aparicio, Ana, Basen-Enngquist, Karen, Logothetis, Christopher J., Gilchrist, Susan C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498569/
https://www.ncbi.nlm.nih.gov/pubmed/37705024
http://dx.doi.org/10.1186/s40959-023-00186-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498569/
https://www.ncbi.nlm.nih.gov/pubmed/37705024
http://dx.doi.org/10.1186/s40959-023-00186-x

Ejemplares similares